Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高级检索
  • Efficacy of the novel Plasmodi...
  • 引用
  • 发送短信
  • 推荐此
  • 打印
  • 导出纪录
    • 导出到 RefWorks
    • 导出到 EndNoteWeb
    • 导出到 EndNote
  • Permanent link
Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

书目详细资料
Main Authors: Minassian, A, Silk, S, Poulton, I, Mitton, C, Payne, R, Rawlinson, T, Barrett, J, Baker, M, Ramon, R, Lopez, F, Edwards, N, Ellis, K, Nielsen, C, Quinkert, D, Barfod, L, Miura, K, Diouf, A, Folegatti, P, Silman, D, Datoo, M, Smith, R, Berrie, E, Morelle, D, Lievens, M, Noe, A, Diggs, C, Soisson, L, Ashfield, R, Long, C, Nugent, F, Lawrie, A, Draper, S
格式: Conference item
出版: American Society of Tropical Medicine and Hygiene 2018
  • 持有资料
  • 实物特征
  • 相似书籍
  • 职员浏览

相似书籍

  • Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
    由: Minassian, AM, et al.
    出版: (2017)
  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
    由: Minassian, AM, et al.
    出版: (2021)
  • Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
    由: Folegatti, P, et al.
    出版: (2019)
  • In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees
    由: Terry, F, et al.
    出版: (2018)
  • Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
    由: Folegatti, PM, et al.
    出版: (2020)

检索选项

  • 检索历史
  • 高级检索

查找更多

  • 浏览目录
  • 按字母顺序浏览
  • 探索频道
  • 课程储备
  • 新项目

需要帮助?

  • 检索技巧
  • 咨询台
  • 常见问题